ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2023年01月13日 17時00分
Source:
Eisai
エーザイ、サステナビリティページ リニューアルのお知らせ
東京, 2023年01月13日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役CEO:内藤晴夫)は、このたび、コーポレートサイトのサステナビリティページを全面リニューアルし、公開しましたので、お知らせします。
「サステナビリティ」トップページ
https://www.eisai.co.jp/sustainability/index.html
当社は、患者様と生活者の皆様の喜怒哀楽を第一義に考え、そのベネフィット向上に貢献する「ヒューマン・ヘルスケア(hhc)」を企業理念とし、この理念のもと、人々の「健康憂慮の解消」や「医療較差の是正」という社会善を効率的に実現することをめざしています。企業理念の実現に向けては、充実したガバナンスのもとで長期的視野に基づく企業施策を実行していくことが必要であり、地球環境や社会的課題の解決に積極的に取り組み、社会のサステナビリティに貢献することは、当社にとって大変重要です。
今回の全面リニューアルでは、当社のサステナビリティに関する考え方や活動の情報をより分かりやすくお届けできるよう内容の充実をはかり、キービジュアル、デザイン、ページ構成を一新しました。当社が注力している「医薬品アクセス向上へ取り組み」のほか、「環境」、「社会」、「ガバナンス」の領域ごとに考え方や目標、取り組み状況を判りやすく紹介しています。
今後も、当社のサステナビリティに関する積極的な情報開示に努め、ステークホルダーズの皆様との良好な関係の維持・発展をはかってまいります。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2023/news202306.html
概要:エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Olympus Announces Milestone for iTind(TM) Device with Expanded Availability Across Major APAC Markets
Feb 26, 2025 11:00 JST
Fujitsu, ANA X, Toshiba Data, and Kawasaki City launch Japan's first pilot program to quantify citizen CO2 reduction
Feb 25, 2025 11:24 JST
Mitsubishi and ENEOS to conduct Front End Engineering Design for Sustainable Aviation Fuel (SAF) Production at the Wakayama Refinery
Feb 24, 2025 12:30 JST
Soligenix's Leadership Aims to Drive Growth in Rare Disease Markets in 2025 and 2026
Feb 22, 2025 04:50 JST
Honda Receives Highest Ranking of 3 Stars as Part of FIA Road Safety Index, Tool for Organizations and Companies to Measure Their Road Safety Footprint
Feb 21, 2025 19:40 JST
Honda Partners with United Nations Road Safety Fund (UNRSF) to Work Toward Reduction of Fatalities from Traffic Collisions
Feb 21, 2025 19:11 JST
Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. Advancing Completely CO2-Free Electrification of Pharmaceutical Transportation
Feb 21, 2025 15:01 JST
NEC Innovation Challenge awards Canada's Prevu3D Inc. with the NEC Award and NOFF Award
Feb 21, 2025 14:39 JST
NEC Develops Near Real-time RIC for High Performance 5G vRAN
Feb 21, 2025 12:00 JST
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
Feb 20, 2025 13:29 JST
NEC X & Carbide Ventures Partner To Rapidly Accelerate Early-Stage Startups
Feb 19, 2025 20:16 JST
Mitsubishi Power Advances Bahrain's Industrial Growth with Completion of Alba's Power Station 5 Block 4 Combined Cycle Power Plant Project
Feb 19, 2025 16:54 JST
Honda Reveals Specification for its Next-generation Fuel Cell Module
Feb 19, 2025 11:07 JST
NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms
Feb 19, 2025 09:08 JST
Osaka Gas and MHI Launch CO2NNEX Digital Platform for Management and Transfer of Clean Gas Certificates for e-Methane, for Use during Expo 2025
Feb 18, 2025 13:18 JST
TOYOTA GAZOO Racing starts WEC season with Qatar challenge
Feb 17, 2025 18:45 JST
FLAT OUT IN TOKYO "Red Bull Showrun x Powered by Honda" April 2 (Wed)
Feb 17, 2025 16:21 JST
Thrilling TOYOTA GAZOO Racing one-two on Swedish snow
Feb 17, 2025 14:23 JST
Launch of Joint Demonstration Experiment of Remote Provision of GPU Computing Power
Feb 17, 2025 14:10 JST
Mazda to Strengthen Production and Sales Systems in Thailand
Feb 14, 2025 17:04 JST
More Latest Release >>
Related Release
Eisai Selected for "Human Capital Leaders 2024" and "Human Capital Management Gold Quality" for Second Consecutive Year, as a Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
2/20/2025 1:29:00 PM JST
Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease
2/14/2025 12:09:00 PM JST
Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies
2/3/2025 5:23:00 PM JST
FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/28/2025 9:46:00 AM JST
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company
1/22/2025 5:18:00 PM JST
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
1/15/2025 10:03:00 AM JST
Elucidation of part of the Mechanism by which Lecanemab Slows the Progression of Alzheimer's Disease
1/7/2025 9:14:00 AM JST
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
12/23/2024 5:22:00 PM JST
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
12/11/2024 2:45:00 PM JST
"LEQEMBI" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
12/5/2024 11:22:00 AM JST
More Press release >>